Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Morgan Eldridge

Nurse Practitioner, Family Waycross, GA Nurse Practitioner

NPI 1639660087 CMS profile 10565740

1507 Alice St, Waycross, GA 31501

Open in the dashboard

General payments

$15,078

394 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Morgan Eldridge of Waycross, GA is reported in the CMS Open Payments database as having received $15,078 across 394 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,211 101
2024 General $4,494 126
2023 General $1,954 71
2022 General $4,495 74
2021 General $1,925 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Morgan Eldridge
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Morgan Eldridge were reported at $2,211. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Morgan Eldridge Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $1,925 $124 $35–$379 $132
2022 $4,495 $141 $44–$430 $149
2023 $1,954 $154 $49–$476 $160
2024 $4,494 $165 $51–$504 $164
2025 $2,211 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $13,021 351 payments
  2. Vertos Medical, Inc. $874 13 payments
  3. Curonix LLC $215 6 payments
  4. SI-BONE, Inc. $196 3 payments
  5. Painteq LLC $142 3 payments
  6. Bayer HealthCare Pharmaceuticals Inc. $125 1 payment
  7. Novo Nordisk Inc $121 2 payments
  8. Alkermes, Inc. $100 1 payment
  9. Amgen Inc. $86 5 payments
  10. Medtronic, Inc. $31 1 payment
  11. Other $167 8 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $11,681 383 payments
  2. Travel and Lodging $3,397 11 payments
Products named General payments · program years 2021–2025
  1. WaveWriter Alpha Prime 16 $5,995 254 payments
  2. Superion Indirect Decompression System $1,621 13 payments
  3. SPECTRA WAVEWRITER $1,244 8 payments
  4. General - Pain Management General - Pain Management_NMD $897 25 payments
  5. mild Device Kit $874 13 payments
  6. WAVEWRITER ALPHA $367 7 payments
  7. GENERAL - PAIN MANAGEMENT Pain Management $253 4 payments
  8. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $215 6 payments
  9. PAINTEQ $142 3 payments
  10. General - Therapies $142 1 payment
  11. Other $1,232 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

323

Median for Nurse Practitioner: 389

Drug cost

$4,236

Median for Nurse Practitioner: $21,885

Branded share of claims

0%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 93 $1,609
Tizanidine Hcl Generic 91 $1,180
Diclofenac Sodium Generic 63 $885
Baclofen Generic 15 $238
Cyclobenzaprine Hcl Generic 18 $179
Meloxicam Generic 31 $75
Methocarbamol Generic 12 $69

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$115,146

Of which drugs: $25

Medicare patients

281

Average age 74

Services billed

1,425

183 women, 98 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 40%
Ischemic heart disease 33%
Chronic kidney disease 29%
Depression 27%
Osteoporosis 25%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
EVENITY
  • Amgen Inc. $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

394 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record